TABLE 3.
HLA A*02 does not modify genotype-specific VE against I181 or I181X virusesa
HLA type | Site 181 | No. of infections |
Est. VE (%) | 95% CI (%) |
P value (H0: VE = 0) | A*02+/− interaction P value | ||
---|---|---|---|---|---|---|---|---|
Vaccine | Placebo | Lower | Upper | |||||
Overall | Match (I) | 40 | 48 | 17 | −26 | 45 | 0.38 | — |
A*02+ | 15 | 27 | 44 | −4 | 70 | 0.068 | 0.08 | |
A*02− | 25 | 21 | −19 | −113 | 33 | 0.56 | ||
Overall | Mismatch (X) | 4 | 18 | 78 | 35 | 93 | 0.0028 | — |
A*02+ | 1 | 10 | 90 | 22 | 99 | 0.028 | 0.29 | |
A*02− | 3 | 8 | 63 | −41 | 90 | 0.15 |
—, not applicable.